Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, B-Cell × Immunoconjugates × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Recurrence 3 Rectal Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Colorectal Neoplasms 2 Stomach Neoplasms 1 Prostatic Neoplasms 1 Multiple Myeloma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, B-Cell 1 Lymphoma 1 Colonic Neoplasms 1 Burkitt Lymphoma 1 Brain Neoplasms 1 Alopecia 1

Interventions

Rituximab 87 Cyclophosphamide 87 fludarabine 53 Doxorubicin 27 Vincristine 25 Prednisone 25 Etoposide 23 Lenalidomide 22 ibrutinib 19 fludarabine phosphate 19 pembrolizumab 15 obinutuzumab 15 Bendamustine Hydrochloride 14 Magnetic Resonance Spectroscopy 13 Immunotherapy, Adoptive 12 Cytarabine 12 Specimen Handling 11 Bortezomib 11 polatuzumab vedotin 10 Gemcitabine 10 CT-P10 10 venetoclax 9 Carboplatin 9 Biopsy 9 pirtobrutinib 8 Radiotherapy 8 Nivolumab 8 Ifosfamide 8 Dexamethasone 8 zanubrutinib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06796517 2025-01-28

Immunotherapy in Lymphoma

Seoul St. Mary's Hospital

Burkitt Lymphoma, Recurrence, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡